Advertisement
Screener

VERICEL CORPORATION (VCEL) Pre-Tax Margin

VERICEL CORPORATION (VCEL) Pre-Tax Margin

  • 2024-12-31: Pre-Tax Margin 26.47%.
  • 2024-09-30: Pre-Tax Margin -1.56%.
  • 2023-12-31: Pre-Tax Margin 21.68%.
  • 2023-09-30: Pre-Tax Margin -8.66%.

Complete source-backed pre-tax margin history.

Available history
2010-06-30 to 2025-12-31
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2024-12-3126.47%
2024-09-30-1.56%
2023-12-3121.68%
2023-09-30-8.66%
2022-12-3112.57%
2022-09-30-17.11%
2022-06-30-24.34%
2022-03-31-19.78%
2021-12-318.95%
2021-09-30-14.62%
2021-06-30-9.60%
2021-03-31-9.36%
2020-12-3128.02%
2020-09-3011.66%
2020-06-30-41.32%
2020-03-31-17.64%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-316.29%
2024-12-314.43%
2023-12-31-1.20%
2022-12-31-9.77%
2021-12-31-4.95%
2020-12-312.50%
2019-12-31-8.20%
2018-12-31-8.96%
2017-12-31-27.54%
2016-12-31-35.98%
2015-12-31-31.93%
2014-12-31-69.18%
2013-12-31-82221.05%
2012-12-31-140352.38%
2011-12-31-109266.67%
2010-06-30-16357.30%

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Greenland Mines Ltd (GRML)United States$2.362B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80